Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

New Predictive Test Gains Momentum With 2 Positive Studies in Localized Colon Cancer

October 26th 2020

Immunoscore®, a host immune response classification tool, has demonstrated the ability to significantly affect treatment decision-making for patients with stage II colon cancer, particularly among those with high-risk disease.

Applying Data to the Real World in Gastric Cancer

October 22nd 2020

Emerging Approaches in HER2+ Gastric Cancers

October 22nd 2020

VEGFR TKIs in Gastroesophageal Cancer

October 22nd 2020

Maintenance Therapy in Gastric Cancers

October 22nd 2020

Adjuvant Treatment in Gastroesophageal Cancer

October 22nd 2020

Looking Toward the Future in Gastroesophageal Cancer

October 22nd 2020

Toxicity Management in Second Line for Gastric Cancer

October 22nd 2020

Clinical Rationale for Antiangiogenics in Gastric Cancer

October 22nd 2020

Predicting Response With Biomarkers in Gastric Cancers

October 22nd 2020

Applying New Data in the Real-World for GEJ Cancer

October 22nd 2020

ESMO 2020: Practice-Changing Data in Esophageal Cancer

October 22nd 2020

First-Line I/O Successful in Gastric Adenocarcinoma

October 22nd 2020

Treatment Landscape in Gastric Cancers Pre-ESMO 2020

October 22nd 2020

Frontline Treatment in Metastatic Gastric Cancer

October 22nd 2020

Optimal Approach Toward Advanced Gastric Cancers in US

October 22nd 2020

Global Trends in Gastric Cancers

October 22nd 2020

Immunotherapy Investigations Lay Groundwork for Future Research Across GI Cancer Settings

October 21st 2020

Manish A. Shah, MD, FASCO, discusses key clinical trials that have evaluated the utility of pembrolizumab and nivolumab in the gastric/gastroesophageal junction cancer, and esophageal squamous cell carcinoma paradigms.

Dr. Lwin on the Design of the LEAP-005 Trial in Pretreated Advanced Solid Tumors

October 20th 2020

Zarnie Lwin, MBBS, FRACP, discusses the design of the phase 2 LEAP-005 trial in previously treated patients with advanced solid tumors.

Dr. Ocean on Determining Optimal Frontline Treatments for Metastatic Pancreatic Cancer

October 20th 2020

Allyson Ocean, MD, discusses determining the optimal frontline treatment of patients with metastatic pancreatic cancer.